Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
N Engl J Med. 2005 Oct 20;353(16):1673-84. doi: 10.1056/NEJMoa052122.
N Engl J Med. 2005.
PMID: 16236738
Free article.
Clinical Trial.